Clinical Challenges: Implementing More Guideline-Endorsed SGLT2i Use

(MedPage Today) -- Newly released heart failure (HF) guidelines extended the recommendation for use of SGLT2 inhibitors as a pillar of therapy for symptomatic HF regardless of ejection fraction or diabetes status--but also challenge practice...